Please join the

National Coalition for Cancer Research and the

American Association for Cancer Research

for our upcoming “Cancer 101” Congressional Briefing Series event:

The Cancer Moonshot Initiative:

Current and Future Cancer Research Objectives

Monday, March 20, 2017

12:00 -1:30 pm

2045 Rayburn House Office Building (formerly B-340)

Register at msmith@libertypartnersgroup.com

Lunch will be served at this widely-attended event.

The Cancer Moonshot initiative is bringing together scientists, oncologists, patient advocates, and representatives of the biopharmaceutical industry with renewed collaborative focus and the ambitious objective of consolidating ten years of cancer research in five years.

On October 27, 2016 the Cancer Moonshot Blue Ribbon Panel released its report that represented the merger of science, technology, advocacy, social science, and big data coming together to solve cancer’s greatest challenges.  A bipartisan Congress provided $1.8 billion over seven years in funding for the initiative as part of the 21st Century Cures Act.  The National Cancer Institute has announced the first series of research projects to be conducted through the Beau Biden Cancer Moonshot program.

Please join us as members of the Cancer Moonshot Blue Ribbon Panel discuss current and future objectives of this unprecedented collaborative effort.  Speakers include:

Douglas R. Lowy, M.D., Acting Director, National Cancer Institute;

George M. Demetri, M.D., Harvard Medical School, Dana Farber Cancer Institute; and

David Arons, J.D., Chief Executive Officer, National Brain Tumor Society

For additional information, please contact Mark Smith at msmith@libertypartnersgroup.com or Mary Lee Watts at marylee.watts@aacr.org.